undamentalytics Newsletter

Stepan Co revenue

Stepan Co's revenue was $2.33bn in fiscal 2025, up 7.0% on the year before. Since fiscal 2009 ($1.28bn) it has grown at a compound 3.8% a year. Over the last twelve months it was $2.43bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Stepan Co: revenue history, annual
Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue1,2761,4311,8431,8041,8811,9271,7761,7661,9251,9941,8591,8702,3462,7732,3262,1802,3322,433
Growth on the year before—+12.1%+28.8%−2.1%+4.3%+2.5%−7.8%−0.6%+9.0%+3.6%−6.8%+0.6%+25.5%+18.2%−16.1%−6.3%+7.0%—
Gross profit233236256292282250308339346339340384396427278272270287
Gross margin18.3%16.5%13.9%16.2%15.0%12.9%17.4%19.2%18.0%17.0%18.3%20.5%16.9%15.4%11.9%12.5%11.6%11.8%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Surfactants $1.7B 71.4% ▲ 8.7%
Polymers $584M 25.1% ▼ 0.1%
Specialty Products $81.7M 3.5% ▲ 29.1%
Geography
Region Revenue YoY
North America $1.3B ▲ 7.9%
United States $1.3B ▲ 8.1%
Europe $543M ▲ 4.9%
Latin America $358M ▲ 11.6%
France $211M ▲ 22.1%
All Other Countries $182M ▲ 0.2%
United Kingdom $170M ▼ 2.9%
Mexico $164M ▲ 9.0%
Brazil $156M ▲ 15.4%
PL $149M ▼ 8.1%
Asia $93.7M ▼ 8.2%

These categories overlap or exclude eliminations, so shares aren't shown.

From Stepan Co's 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Specialty Chemicals: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Stepan Co $2.43bn 7.6% -1.9%
Minerals Technologies Inc $2.17bn 4.8% 0.3%
Newmarket Corp $2.77bn 0.9% 0.4%
Quaker Chemical Corp $2.03bn 8.7% 0.9%
Innospec Inc. $1.84bn 2.9% -2.9%
Ashland Inc. $1.84bn -1.4% -7.2%

Compare with peers

Head to head: MTX vs SCLNEU vs SCLKWR vs SCL

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from Stepan Co's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Stepan Co.